SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Thermo Tech Technologies (TTRIF)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Pickering who wrote (4249)6/3/1998 12:10:00 PM
From: Zeev Hed  Read Replies (1) of 6467
 
David, thanks for the stock proliferation accounting, it explains a lot. Am I to understand that there will still be about $16 MM of the Leaky debenture" left, in case TTRIF needs to go back to the well?

As for extension, patents on genetically engineered drugs are the only one that can be extended, if the holder of the patent can show that the FDA's PMA process was particularly lengthy and thus did not leave enough Life" in the patent normal 20 years life (from filing date). I am not sure if this term applies to the thermophilic process since they were no PMA steps required.

As for the lag between "allowance" of a patent and its issue date, unless there is intervention from the department of defense (it happened to me on three or so patents), under the guise that issuance of the patent will have national defense implications (one of my patents was enabling the development of submarine caterpilar drives), is typically 3 months.

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News